stanozolol has been researched along with Complication, Postoperative in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blamey, SL; Burns, P; Carter, DC; Forbes, CD; Lowe, GD; McArdle, BM; Prentice, CR | 1 |
| Blamey, SL; Burns, P; Carter, DC; Forbes, CD; Lowe, GD; McArdle, BM | 1 |
| Bertina, RM; Blamey, SL; Forbes, CD; Kluft, C; Lowe, GD; Malia, RG; Preston, FE | 1 |
| Maves, KK; Weiler, JM | 1 |
| Agostoni, A; Castelli, R; Cicardi, M; Gardinali, M; Munari, M; Savi, C; Zingale, LC | 1 |
| Cooper, RG; Illingworth, KJ; Jayson, MI; Mitchell, WS | 1 |
| Berridge, DC; Frier, M; Hopkinson, BR; Makin, GS; Westby, JC | 1 |
| Blamey, SL; Carter, DC; Douglas, JT; Forbes, CD; Lowe, GD | 1 |
| Franks, AJ; Hosegood, JL | 1 |
| Davies, JA; Kluft, C; Prentice, CR; Sue-Ling, HM; Verheijen, JH | 1 |
| Bertina, RM; Blamey, SL; Davies, JA; Forbes, CD; Kluft, C; Lowe, GD; Sue-Ling, HM | 1 |
| Blamey, SL; Cuschieri, RJ; Forbes, CD; Lowe, GD; McArdle, CS; Morran, CG | 1 |
5 trial(s) available for stanozolol and Complication, Postoperative
| Article | Year |
|---|---|
Fibrinolytic enhancement with stanozolol fails to improve symptoms and signs in patients with post-surgical back pain.
Topics: Adult; Aged; Back Pain; Cohort Studies; Female; Fibrinolysis; Humans; Male; Middle Aged; Postoperative Complications; Postoperative Period; Stanozolol | 1991 |
Double-blind randomized trial of perioperative fibrinolytic enhancement for femoropopliteal bypass.
Topics: Aged; Double-Blind Method; Femoral Artery; Fibrinogen; Humans; Plasminogen; Popliteal Artery; Postoperative Care; Postoperative Complications; Stanozolol; Thrombolytic Therapy; Thrombosis | 1991 |
Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Topics: Beta-Globulins; beta-Thromboglobulin; Clinical Trials as Topic; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Peptide Fragments; Postoperative Complications; Stanozolol; Thrombophlebitis | 1985 |
Protein C antigen levels in major abdominal surgery: relationships to deep vein thrombosis, malignancy and treatment with stanozolol.
Topics: Adult; Aged; Blood Proteins; Female; Glycoproteins; Humans; Immunoenzyme Techniques; Laparotomy; Male; Middle Aged; Neoplasms; Postoperative Complications; Protein C; Stanozolol; Thrombophlebitis | 1985 |
The effect of fibrinolytic stimulation by stanozolol on postoperative pulmonary complications.
Topics: Adult; Aged; Female; Fibrinolysis; Humans; Hypoxia; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Stanozolol | 1985 |
7 other study(ies) available for stanozolol and Complication, Postoperative
| Article | Year |
|---|---|
Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Anabolic Agents; Androgens; Biomarkers; Blood Viscosity; Case-Control Studies; Elective Surgical Procedures; Female; Fibrinogen; Fibrinolysis; Humans; Injections, Intramuscular; Liver Function Tests; Male; Middle Aged; Plasminogen; Plasminogen Activators; Postoperative Complications; Preoperative Care; Stanozolol; Time Factors; Venous Thrombosis | 1983 |
A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Topics: Abdomen; Aged; Double-Blind Method; Female; Fibrinolysis; Humans; Injections, Intramuscular; Male; Middle Aged; Plasminogen Activators; Postoperative Complications; Random Allocation; Stanozolol; Thrombophlebitis | 1984 |
Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol.
Topics: Adult; Aged; Blood Coagulation Factors; Female; Fibrinolysis; Gastrointestinal Diseases; Glycoproteins; Humans; Injections, Intramuscular; Male; Middle Aged; Postoperative Complications; Protein C; Stanozolol; Thrombophlebitis | 1984 |
Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate.
Topics: Adolescent; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Humans; Male; Postoperative Complications; Stanozolol; Tonsillectomy | 1994 |
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
Topics: Aged; Anabolic Agents; Angioedema; Antifibrinolytic Agents; Aprotinin; Autoimmune Diseases; Calcium Channel Blockers; Cardiopulmonary Bypass; Complement Activation; Complement C1 Inactivator Proteins; Coronary Artery Bypass; Hemostatics; Heparin Antagonists; Humans; Laryngeal Edema; Male; Myocardial Infarction; Postoperative Complications; Protamines; Recurrence; Stanozolol; Tranexamic Acid | 1997 |
Response of human skeletal muscle to the anabolic steroid stanozolol.
Topics: Abdomen; Humans; Muscles; Postoperative Complications; Stanozolol; Thrombophlebitis | 1988 |
Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Topics: Fibrinolysis; Glycoproteins; Heparin; Humans; Plasminogen Inactivators; Postoperative Complications; Stanozolol; Thrombophlebitis; Time Factors | 1985 |